IP40: Kidney Cancer: Localized: Surgical Therapy III
Saturday, May 16, 2026 1:00 PM to 3:00 PM · 2 hr. (America/New_York)
146C
Poster and Podium Sessions
Oncology: Kidney
Saturday, May 16
IP40-01: Optimization of Postoperative Care for Nephrectomy Patients Using the UroConnect Telemonitoring Tool (UroCCR n°129)
Saturday, May 16, 2026 1:00 PM to 3:00 PM
146C
IP40-02: Preoperative Frailty Measured by the Geriatric 8 Predicts Surgical Morbidity and Survival After Radical Nephroureterectomy in Elderly Patients with Upper Tract Urothelial Carcinoma
Saturday, May 16, 2026 1:00 PM to 3:00 PM
146C
IP40-03: Association between preoperative hemoglobin A1c and perioperative outcomes in patients undergoing extirpative kidney surgery
Saturday, May 16, 2026 1:00 PM to 3:00 PM
146C
IP40-04: Towards Gender Equity in Renal Surgery: Understanding Sex-Based Differences in Perioperative Outcomes
Saturday, May 16, 2026 1:00 PM to 3:00 PM
146C
IP40-05: Cardiovascular health in renal cell carcinoma: analysis of a modified Life’s Essential 8 score
Saturday, May 16, 2026 1:00 PM to 3:00 PM
146C
IP40-06: Artificial Intelligence for Predicting Perioperative Outcomes From Preoperative Imaging in Kidney Tumor Patients
Saturday, May 16, 2026 1:00 PM to 3:00 PM
146C
IP40-07: A Contemporary Analysis of Laparoscopic Hand-Assisted versus Robotic-Assisted Radical Nephrectomy for Renal Masses
Saturday, May 16, 2026 1:00 PM to 3:00 PM
146C
IP40-08: Oncologic and Perioperative Outcomes of the Midline Extraperitoneal Approach for Radical Nephrectomy
Saturday, May 16, 2026 1:00 PM to 3:00 PM
146C
IP40-09: Organ-Preserving versus Radical Surgical Approaches for Complex Renal Tumors (RENAL =10): High-Volume Center Results
Saturday, May 16, 2026 1:00 PM to 3:00 PM
146C
IP40-10: Transperitoneal versus Retroperitoneal Single Port Robotic Nephroureterectomy: A Multi-Institutional Comparison Analysis from the Single Port Advanced Research Consortium (SPARC)
Saturday, May 16, 2026 1:00 PM to 3:00 PM
146C
IP40-11: Papillary Renal Neoplasm with Reverse Polarity—a Comparative Study with CCPRCC, OPRCC, and PRCC1
Saturday, May 16, 2026 1:00 PM to 3:00 PM
146C
IP40-12: Renal Function Preservation with Neoadjuvant Therapy in Renal Cell Carcinoma Patients with Chronic Kidney Disease
Saturday, May 16, 2026 1:00 PM to 3:00 PM
146C
IP40-13: Prognostic Implications of Nodal Status in Localized and Locally-Advanced Renal Cell Carcinoma: Analysis from the NCDB
Saturday, May 16, 2026 1:00 PM to 3:00 PM
146C
IP40-14: Kidney only recurrence is higher in synchronous bilateral non-metastatic renal cell carcinoma without hereditary syndromes compared to a matched cohort of unilateral tumors
Saturday, May 16, 2026 1:00 PM to 3:00 PM
146C
IP40-15: Underutilization of Renal Mass Biopsy Prior to Ablation: Implications for Benign Diagnosis and Kidney Function
Saturday, May 16, 2026 1:00 PM to 3:00 PM
146C
IP40-16: The impact of time to local tumor destruction on cancer-specific mortality in pT1a renal cell carcinoma
Saturday, May 16, 2026 1:00 PM to 3:00 PM
146C
IP40-17: Partial nephrectomy (PN) versus ablative therapies (AT) for T1a clear cell renal cell carcinoma (ccRCC): analysis of 2,161 patients
Saturday, May 16, 2026 1:00 PM to 3:00 PM
146C
IP40-18: Microwave Ablation has similar oncologic outcomes to partial nephrectomy and radical nephrectomy for clinical stage 1 renal cell carcinoma
Saturday, May 16, 2026 1:00 PM to 3:00 PM
146C
IP40-19: Integrating Systemic Inflammatory Markers (MLR, PLR, and SII) into a Composite Preoperative Score Enhances Prognostic Accuracy and Detects Venous Tumor Thrombus in Renal Cell Carcinoma
Saturday, May 16, 2026 1:00 PM to 3:00 PM
146C
Zheng Song
IP40-20: Predictors of Major Complications after Nephrectomy with Tumor Thrombectomy: A National Surgical Quality Improvement Plan Study
Saturday, May 16, 2026 1:00 PM to 3:00 PM
146C
IP40-21: Contemporary outcomes of nephrectomy with IVC thrombectomy: Analysis from a large multi-institutional database
Saturday, May 16, 2026 1:00 PM to 3:00 PM
146C
IP40-22: Perioperative outcomes of open versus robot-assisted radical nephrectomy with IVC thrombectomy thrombectomy.
Saturday, May 16, 2026 1:00 PM to 3:00 PM
146C
IP40-23: The Safety and Feasibility of Segmental Inferior Vena Cava Resection in Renal Cell Carcinoma with Venous Tumor Thrombus: A Large Retrospective Cohort Study
Saturday, May 16, 2026 1:00 PM to 3:00 PM
146C
Peng Hong
IP40-24: Robot-assisted Laparoscopic "Thrombus-First" Technique for Left Renal Cell Carcinoma with Inferior Vena Cava Tumor Thrombus (IVT)
Saturday, May 16, 2026 1:00 PM to 3:00 PM
146C
IP40-25: Robot-Assisted Radical Nephrectomy with Level II Caval Thrombectomy Using the Hugo™ RAS System: First Experience and Step-by-Step Surgical Technique
Saturday, May 16, 2026 1:00 PM to 3:00 PM
146C
IP40-26: RESECTION OF ATRIAL-LEVEL RENAL CELL CARCINOMA TUMOR THROMBI USING DEEP HYOPTHERMIC CIRCULATORY ARREST
Saturday, May 16, 2026 1:00 PM to 3:00 PM
146C
Kyle Blum
IP40-27: Long-term Treatment-free Cancer Control Achieved through Deferred Cytoreductive Nephrectomy in Selected Patients with mRCC
Saturday, May 16, 2026 1:00 PM to 3:00 PM
146C
IP40-28: RCC patients with isolated contralateral kidney recurrence have worse outcomes compared to unilateral RCC patients
Saturday, May 16, 2026 1:00 PM to 3:00 PM
146C
IP40-29: Impact of Mayo Adhesive Probability (MAP) Score on Perioperative Outcomes of off-clamp Single-Port Partial Nephrectomy: A Comparison Between Transperitoneal and Extraperitoneal Approaches
Saturday, May 16, 2026 1:00 PM to 3:00 PM
146C
IP40-30: COMPLETION NEPHRECTOMY OUTCOMES FOLLOWING PRIOR PARTIAL NEPHRECTOMY IN HEREDITARY KIDNEY CANCER SYNDROMES
Saturday, May 16, 2026 1:00 PM to 3:00 PM
146C
Patrick Michael · NCI/NIH
